APA (7th ed.) Citation

C, P., G, A., C, L., A, G., G, I., D, P., . . . A, S. (2026). Echocardiographic effects of dupilumab in patients with severe type 2 asthma. Pulmonary pharmacology & therapeutics, 92, 102409. https://doi.org/10.1016/j.pupt.2026.102409

Chicago Style (17th ed.) Citation

C, Pelaia, et al. "Echocardiographic Effects of Dupilumab in Patients with Severe Type 2 Asthma." Pulmonary Pharmacology & Therapeutics 92 (2026): 102409. https://doi.org/10.1016/j.pupt.2026.102409.

MLA (9th ed.) Citation

C, Pelaia, et al. "Echocardiographic Effects of Dupilumab in Patients with Severe Type 2 Asthma." Pulmonary Pharmacology & Therapeutics, vol. 92, 2026, p. 102409, https://doi.org/10.1016/j.pupt.2026.102409.